Gut-Brain Axis: History and Origins

The "gut-brain axis" is not an invention with a single founder, and no one person discovered it. It is a scientific idea that was built up, piece by piece, over nearly two centuries — from a frontier surgeon watching emotion change digestion through a hole in a living man's stomach, to physiologists who proved the gut runs partly on its own, to the modern realization that the trillions of microbes living inside us are part of the conversation. This article traces that real lineage and the named people behind it: William Beaumont and his patient Alexis St. Martin; William Bayliss and Ernest Starling, who found the first hormone in the gut; Ivan Pavlov and Walter Cannon; Michael Gershon and the "second brain"; and the microbiome researchers — Nobuyuki Sudo, John Cryan, Ted Dinan and others — who turned a fringe notion into a mainstream field. It also states plainly where the science is solid and where the popular claims have run ahead of the evidence. Where the record is firm we say so; where a claim is still being tested or oversold, we name that too.

Table of Contents

  1. An Ancient Intuition: The Gut as a Seat of Feeling
  2. Beaumont and St. Martin: A Window Into the Stomach (1822–1833)
  3. Bayliss, Starling and the First Hormone (1902)
  4. Pavlov and Cannon: The Brain Talks to the Gut
  5. Gershon and the "Second Brain" (1998)
  6. The Microbial Turn: Sudo, Cryan and Dinan (2004 onward)
  7. Naming the Axis and the Rise of "Psychobiotics"
  8. Evidence and Reception: What Is Solid, What Is Hype
  9. Research Papers and References
  10. Connections
  11. Featured Videos

An Ancient Intuition: The Gut as a Seat of Feeling

Long before there was a science of it, people sensed a link between the belly and the mind. Everyday language still carries that intuition: we speak of a "gut feeling," of being "sick with worry," of decisions made "from the gut." Across many cultures the abdomen was treated as a seat of emotion and instinct, not merely a food-processing organ. These are folk observations, not medical proof — but they matter to the history, because the modern gut-brain axis is, in a sense, the slow scientific vindication of something ordinary people had always felt.

The phrase often attributed to Hippocrates — "all disease begins in the gut" — is a useful illustration of how careful a history like this has to be. It is repeated constantly in popular writing on gut health, yet there is no reliable source showing Hippocrates actually wrote those exact words; it is best treated as a modern paraphrase or aphorism rather than a genuine ancient quotation. We mention it here only to flag it as folklore, not as documented fact. The honest starting point for the documented history is not an ancient saying but a nineteenth-century accident.

Back to Table of Contents

Beaumont and St. Martin: A Window Into the Stomach (1822–1833)

The first hard, documented evidence that emotion changes digestion came from one of the strangest patient-doctor relationships in medical history. On June 6, 1822, a young French-Canadian fur trapper named Alexis St. Martin was accidentally shot at close range with a musket at a trading post on Mackinac Island, Michigan. The wound to his abdomen was severe, but it healed in an unusual way: it formed a permanent opening — a gastric fistula — through which the inside of his stomach could literally be seen and reached from outside the body.

The U.S. Army surgeon who treated him, Dr. William Beaumont (1785–1853), recognized an extraordinary research opportunity. Over roughly the next decade, with St. Martin's intermittent and often reluctant cooperation, Beaumont performed on the order of two hundred and fifty experiments, frequently by tying food to a string, lowering it through the fistula into the stomach, and withdrawing it at intervals to watch how digestion progressed. He published the results in 1833 as Experiments and Observations on the Gastric Juice, and the Physiology of Digestion, work that earned him the later title "father of gastric physiology."

For the gut-brain story, the crucial detail is this: among his observations, Beaumont recorded that St. Martin's emotional state altered his digestion. When the man was angry, irritable, or upset, Beaumont noted changes in the stomach — including disturbed gastric secretion and motility. It was a small part of a much larger body of work, and only a handful of the experiments touched on emotion, but it stands as the earliest documented Western evidence that the brain and the gut are physiologically linked. It is also worth saying plainly that this research would be considered deeply unethical today: St. Martin was a poor, dependent man experimented upon for years, and the modern field rests, uncomfortably, on that history.

Back to Table of Contents

Bayliss, Starling and the First Hormone (1902)

If Beaumont showed that the brain could reach the gut, the next great step showed that the gut could send chemical messages of its own — the discovery that launched the entire concept of hormonal signaling. On 16 January 1902, working at University College London, the physiologists William Bayliss (1860–1924) and Ernest Starling (1866–1927) performed a now-famous experiment on anaesthetized dogs. They showed that when acidic, partially digested food reaches the small intestine, the lining of the gut releases a substance into the bloodstream that travels to the pancreas and tells it to secrete digestive juice.

They named that substance secretin, and it was the first hormone ever identified. A few years later, in 1905, Starling introduced the word "hormone" — from the Greek for "to set in motion" — to describe this new class of blood-borne chemical messengers. The discovery is securely documented and is one of the foundational moments of modern physiology and endocrinology.

Why does a 1902 pancreas experiment belong in a history of the gut-brain axis? Because it established, with hard evidence, that the gut is an endocrine and signaling organ — not a passive tube but a tissue that produces messengers capable of acting at a distance on the rest of the body. The modern gut-brain axis is, in large part, the study of exactly such signals: hormones, peptides, and metabolites made in the gut that influence the brain. Bayliss and Starling did not study the brain here, but they proved the principle on which the whole field would later stand.

Back to Table of Contents

Pavlov and Cannon: The Brain Talks to the Gut

In the same era, two other giants of physiology nailed down the reverse direction — how the brain and emotions reach down into the gut. The Russian physiologist Ivan Pavlov (1849–1936), best remembered for conditioned reflexes, won the 1904 Nobel Prize in Physiology or Medicine for his work on digestion. He demonstrated the "cephalic phase" of digestion: the sight, smell, or even the anticipation of food — signals originating in the brain — triggers gastric and pancreatic secretion before any food is eaten. This was rigorous proof that the nervous system drives digestive function from the top down.

The American physiologist Walter Bradford Cannon (1871–1945) pushed the point into the realm of emotion. Using the then-new X-ray (Röntgen rays), Cannon watched the stomachs of animals in real time and found that fear, rage, and distress halted gastric movement: a calm cat's stomach showed normal peristaltic waves, while an anxious or enraged one's stomach stopped moving. He gathered these findings in his 1915 book Bodily Changes in Pain, Hunger, Fear and Rage and coined the phrase "fight or flight" to describe the body's emergency response. Cannon also gave us the concept of homeostasis.

By the early twentieth century, then, the two-way street was scientifically established: Beaumont, Pavlov, and Cannon had shown that the brain and emotions change the gut, and Bayliss and Starling had shown that the gut sends chemical signals outward. What was still completely missing from the picture — for another century — was the role of the microbes.

Back to Table of Contents

Gershon and the "Second Brain" (1998)

The gut, it turned out, has a nervous system of its own. The enteric nervous system (ENS) — a vast mesh of neurons embedded in the wall of the digestive tract — had been described in the nineteenth century, but its full significance was not widely appreciated until the work of Dr. Michael D. Gershon, a professor of pathology and cell biology at Columbia University. Gershon's research showed that the ENS can coordinate digestion largely on its own, without instructions from the brain or spinal cord, and he is widely credited with helping establish the field of neurogastroenterology; he is often called its "father."

Gershon also did pivotal work on serotonin in the gut, helping to establish it as a signaling molecule of the digestive tract — relevant because the great majority of the body's serotonin is in fact made in the gut, not the brain. In 1998 he published a popular book, The Second Brain, which brought these ideas to a wide audience and gave the field its most memorable nickname. The phrase "second brain" is a vivid metaphor for the ENS's size and autonomy, and it stuck.

A word of caution about the metaphor: the gut's nervous system is genuinely large and genuinely capable of acting independently, but calling it a "brain" is a figure of speech, not a literal claim that the gut thinks or feels as the brain does. Gershon's real contribution was rigorous neuroscience; the catchy label is best understood as the popular shorthand it was meant to be. His work set the stage for the final, transformative chapter — the discovery that the microbes living alongside that "second brain" are themselves part of the system.

Back to Table of Contents

The Microbial Turn: Sudo, Cryan and Dinan (2004 onward)

For most of the twentieth century, the gut-brain axis meant nerves and hormones. The microbes were left out — partly because the tools to study them did not yet exist. That changed dramatically in the early twenty-first century, when affordable DNA sequencing made it possible to map the gut's microbial communities, and a series of experiments suggested those microbes were talking to the brain.

The widely cited turning point is a 2004 study by the Japanese researchers Nobuyuki Sudo and Yoichi Chida and colleagues, published in The Journal of Physiology. They showed that germ-free mice — animals raised with no gut bacteria at all — had an exaggerated hormonal stress response (an over-reactive hypothalamic-pituitary-adrenal, or HPA, axis), and that this abnormality could be partly corrected by colonizing the mice with a specific bacterium, Bifidobacterium infantis. In other words, the presence or absence of gut microbes physically shaped the brain's stress machinery. This finding electrified the field and is generally regarded as the moment the modern microbiota-gut-brain axis was born.

Through the 2000s and 2010s, much of the foundational work that followed came from a research group at University College Cork in Ireland, especially the neuroscientist John F. Cryan and the psychiatrist Ted (Timothy) Dinan, along with many collaborators worldwide. Germ-free animal studies, vagus-nerve experiments, and early human trials built up a picture in which gut bacteria could influence mood, stress, and behavior. In 2019, Cryan and a large team published a sweeping synthesis, "The Microbiota-Gut-Brain Axis," in Physiological Reviews — a marker of how far an idea once considered fringe had moved toward the scientific mainstream.

Back to Table of Contents

Naming the Axis and the Rise of "Psychobiotics"

The term "gut-brain axis" itself has no single inventor and no precise birthday; it emerged gradually in the physiology and gastroenterology literature of the late twentieth century as a convenient label for the two-way communication between the digestive system and the central nervous system. As the microbial dimension came into focus after 2004, the phrase was extended to "microbiota-gut-brain axis" or "microbiome-gut-brain axis" to make explicit that the bacteria are part of the loop. These are descriptive scientific terms that grew with the field, not brand names coined by one person.

One term in this story does have a clear origin. In 2013, Ted Dinan, Catherine Stanton, and John Cryan introduced the word "psychobiotics" in the journal Biological Psychiatry, defining it as a live organism that, taken in adequate amounts, produces a mental-health benefit in people with psychiatric illness. The concept was later broadened to include prebiotics and other microbiome-targeted interventions with psychological effects. The word captured a genuinely new idea — that you might treat the mind by deliberately altering the gut's bacteria — and it has become one of the most-used terms in the field.

It is worth being precise here, because popular writing often blurs it: the gut-brain axis is a body of science describing real anatomy and signaling, while "psychobiotics" names a therapeutic hypothesis built on that science. The first is well established; the second is an active and still-maturing area of treatment research, which leads to the most important section of this history — an honest accounting of the evidence.

Back to Table of Contents

Evidence and Reception: What Is Solid, What Is Hype

Because the gut-brain axis is fashionable, it attracts both serious science and a great deal of overstatement. Telling the two apart is the whole point of an honest history. Here is the careful picture as the mainstream research community understands it.

What is well established. The existence of rich, two-way communication between the gut and the brain is not in doubt. The vagus nerve carries signals in both directions; the gut is a major endocrine organ; the enteric nervous system is real and largely autonomous; and gut bacteria produce neuroactive compounds and influence the immune and stress systems. The general principle that gut health and brain health are connected is solid, mainstream physiology.

Where the evidence is still developing. Much of the most dramatic data — that transferring microbes can transmit anxiety- or depression-like behavior, or reverse it — comes from germ-free and other animal models, which are powerful for showing what is possible but do not automatically apply to humans. Human trials of probiotics and "psychobiotics" for depression, anxiety, and related conditions have produced some encouraging results, but the studies are often small, short, use different strains and doses, and yield mixed or modest effects. Reviewers consistently caution that, at present, these interventions are best seen as complementary or adjunctive — possible supports alongside standard care — and not as proven replacements for established treatments for any psychiatric or neurological illness.

Where popular claims outrun the science. The commercial and wellness worlds have raced far ahead of the data. Confident assertions that a particular probiotic, cleanse, supplement, or "gut reset" will cure depression, reverse autism, or prevent Parkinson's or Alzheimer's disease are not supported by the current evidence. Specific points deserve a flag: the popular concept of "leaky gut" as the root of most chronic disease is far more sweeping than what controlled research supports, even though increased intestinal permeability is a real and studied phenomenon; and the famous line "all disease begins in the gut" is a slogan, not a scientific finding. Fecal microbiota transplantation (FMT) is an established, evidence-based treatment for one specific problem — recurrent Clostridioides difficile infection — but its use for psychiatric or neurological conditions remains experimental.

The fair summary is this: the gut-brain axis is one of the most genuinely exciting frontiers in modern medicine, built on two centuries of solid discovery by named, careful scientists. It is also one of the most heavily marketed, where real findings are routinely stretched into claims they cannot bear. Understanding the true history — what was actually shown, by whom, and how strongly — is the best protection against both dismissing the science and being sold the hype.

Back to Table of Contents

Research Papers and References

The list below combines key peer-reviewed and historical sources with curated PubMed topic-search links into the gut-brain literature. Author names, titles, and journals are given as plain text; only the stable DOI, PMID, or archive link is hyperlinked, and each opens in a new tab. Older works (Beaumont 1833; Cannon 1915) are named in the article as historical primary sources and are listed below with stable archive links where available.

  1. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology. 2004;558(Pt 1):263-275. — doi:10.1113/jphysiol.2004.063388
  2. Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiological Reviews. 2019;99(4):1877-2013. — doi:10.1152/physrev.00018.2018
  3. Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biological Psychiatry. 2013;74(10):720-726. — doi:10.1016/j.biopsych.2013.05.001
  4. Mayer EA, Nance K, Chen S. The Gut-Brain Axis. Annual Review of Medicine. 2022;73:439-453. — doi:10.1146/annurev-med-042320-014032
  5. Henriksen JH, de Muckadell OB. Secretin, its discovery, and the introduction of the hormone concept. Scandinavian Journal of Clinical and Laboratory Investigation. 2000;60(6):463-471. — PMID: 11129062
  6. Beaumont W. Experiments and Observations on the Gastric Juice, and the Physiology of Digestion. Plattsburgh: F. P. Allen; 1833. — Internet Archive (full text)
  7. Cannon WB. Bodily Changes in Pain, Hunger, Fear and Rage. New York: D. Appleton; 1915. — Internet Archive (full text)
  8. Gut-brain axis — history and concept — PubMed: gut-brain axis history and concept
  9. Microbiota-gut-brain axis — germ-free mice and behavior — PubMed: microbiota-gut-brain axis, germ-free mice

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents